(Total Views: 442)
Posted On: 04/04/2020 1:45:16 PM
Post# of 153890

Re: Goosebumps #25408
I wouldn't use the annual numbers for HIV/Cancer as a benchmark. Tx for CV-19 will be much shorter and less costly. Still a lot of revenue for sure.

